Table 1.
Patient clinicopathologic characteristics.
| Clinicopathologic Characteristic | Mean/Median or Incidence | IQR/95% CI or % |
|---|---|---|
| Age (years) | 78 | 74–81 |
| Male sex | 15 | 79 |
| Race | ||
| NH White | 17 | 89 |
| NH Black | 2 | 11 |
| Body Mass Index (kg/m2) | 28 | 25–31 |
| Tobacco Use | 12 | 63 |
| Charlson Comorbidity Index | 7 | 6–9 |
| ECOG Performance Status | ||
| 0 | 5 | 26 |
| 1 | 9 | 47 |
| 2 | 5 | 26 |
| Clinical Stage | ||
| I* | 1 | 3 |
| II | 16 | 84 |
| III | 1 | 3 |
| IV | 1 | 3 |
| T2 | 17 | 89 |
| N0 | 16 | 84 |
| Histology | ||
| Urothelial | 17 | 89 |
| Squamous | 1 | 5 |
| Small cell | 1 | 5 |
| Differentiation Pattern | ||
| Papillary | 5 | 26 |
| Sarcomatoid | 2 | 11 |
| Plasmacytoid | 1 | 5 |
| Squamous | 4 | 21 |
| Not otherwise specified | 8 | 42 |
| Grade | ||
| High | 16 | 84 |
| Moderate | 1 | 3 |
| MIBC | 17 | 89 |
| Tumor Location | ||
| Dome | 2 | 11 |
| Lateral Wall | 7 | 37 |
| Posterior Wall | 4 | 21 |
| Trigone/Neck | 3 | 16 |
| Multifocal | 3 | 16 |
| Maximum Tumor Diameter | 4.18 | 3.22–5.12 |
| Chemotherapy | ||
| MMC/5FU | 15 | 79 |
| Gemcitabine | 2 | 11 |
| Cisplatin | 2 | 11 |
*
Small cell carcinoma of the bladder